Conversations in Oncology - FREE Virtual Conference!

There is no registration fee for this CME live virtual conference! Link to Register: http://naceonline.com/CME-Courses/course_info.php?course_id=1071

May 18, 2019 Broadcast Live from Ft. Lauderdale, FL Start Time: 9:00 am EDT

Program Summary:

Join Rasim A. Gucalp, MD, FACP and stay on track to fulfill your CME requirements from the comfort of your home. Utilizing an interactive, moderator led format, this program will present discussions with national thought leaders to help you hone your skills in the diagnosis and management of patients you are likely encountering in your practice. You will be able to interact with the faculty real-time to get your questions answered.

Learning Objectives: At the conclusion of this program, participants should be able to:

Use patient’s age, prognostic markers, co-morbidities and patient’s preferences when individualizing CLL management; Utilize new and emerging therapies as well as chemo-immunotherapy for the appropriate patients with CLL; Consider depth of response including MRD negativity in managing care; Recognize and manage the common complications related to the medications used to treat CLLRecognize the need for testing for epidermal growth factor receptor (EGFR) mutations in patients with non-small cell lung cancer (NSCLC); Recognize the role of mechanisms of resistance of EGFR inhibitors in the treatment of patients with NSCLC; Integrate the latest clinical data on EGFR inhibitors when developing an individualized treatment strategy for patients with NSCLC; Identify the adverse effects of EGFR inhibitor treatment in NSCLC

Agenda*

9:00-9:05 AM

Welcome Remarks Rasim Gucalp, MD

9:05-10:05

Clinical Advances: Individualizing Treatment for Chronic Lymphocytic Leukemia Noah Kornblum, MD Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd Moderator Rasim Gucalp, MD

10:05-10:10 Break10:10-11:15 Targeting Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer: Advances in Treatment Balazs Halmos, MD Moderator Rasim Gucalp, MD11:15-11:20 Break11:20-11:50 Panel Q&A Rasim Gucalp, MD Noah Kornblum, MD Balazs Halmos, MD11:50-11:55 Closing Remarks Rasim Gucalp, MD

* Subject to Change

Faculty

Balazs Halmos, MD Professor, Department of Medicine (Oncology) Albert Einstein College of Medicine Director of Thoracic/Head and Neck Oncology and Clinical Cancer Genomics Montefiore Medical Center Bronx, NY

Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd Chief Medical Officer and Executive Vice President CLL Society Claremont, CA

Noah Kornblum, MD Assistant Professor, Department of Medicine (Oncology) Bone Marrow Transplant/Heme Malignancy Montefiore Einstein Center for Cancer Care Bronx, NY

Moderator Rasim A. Gucalp, MD, FACP – Course Director Professor, Department of Medicine (Oncology) Albert Einstein College of Medicine Montefiore Medical Center Director, Hematology/Oncology Fellowship Program Bronx, NY

Planning Committee Sandy Bihlmeyer, M.Ed. Senior Project Manager National Association for Continuing Education Plantation, FL

Michelle Frisch, MPH, CHCP Vice-President National Association for Continuing Education Plantation, FL

Daniela Hiedra Activity Director National Association for Continuing Education Plantation, FL

Joshua F. Kilbridge President and Creative Director Kilbridge Associates San Francisco, CA

Gregg Sherman, MD Chief Medical Officer National Association for Continuing Education Plantation, FL

Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd Chief Medical Officer and Executive Vice President CLL Society Claremont, CA

Sponsored and Certified By Albert Einstein College of Medicine Accreditation Designation Statement Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 2.5 Contact hours of continuing education which includes pharmacology hours.Faculty Disclosure Policy Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.Commercial Support This activity is supported by an educational grant from Pharmacyclics, LLC and an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.